Erythromycin stearate is the generic ingredient in eight branded drugs marketed by Bristol, Parke Davis, Warner Chilcott, Arbor Pharms Llc, Ani Pharms Inc, Lederle, Mylan, Purepac Pharm, Watson Labs, Bristol Myers Squibb, Pfizer, and Wyeth Ayerst, and is included in fifteen NDAs. Additional information is available in the individual branded drug profile pages.
There are ninety-five drug master file entries for erythromycin stearate.
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||Type||RLD||Patent No.||Patent Expiration||Exclusivity Expiration|
|Tablet; Oral||061675||Approved prior to Jan 1, 1982||RX||No||<disabled>||<disabled>|
|Tablet; Oral||060359||Approved prior to Jan 1, 1982||DISCN||No||<disabled>||<disabled>|
Bristol Myers Squibb
|Tablet; Oral||061605||Approved prior to Jan 1, 1982||DISCN||No||<disabled>||<disabled>|
|Tablet; Oral||062121||Approved prior to Jan 1, 1982||RX||No||<disabled>||<disabled>|
|Tablet; Oral||062089||Approved prior to Jan 1, 1982||DISCN||No||<disabled>||<disabled>|
|This preview shows a limited data set|
Subscribe for full access, or try a free trial
Export unavailable in trial.
Subscribe for complete access.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.